New Scientific Approaches in Reproductive Medicine. At ReproNovo, we are passionate about bringing the dream of parenthood to life.
Total raised: $65M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 26.05.2025 | Series A | $65M | - |
Mentions in press and media 7
| Date | Title | Description |
| 26.05.2025 | ReproNovo: $65 Million Series A Raised For Advancing Reproductive Medicine And Women’s Health Therapies | ReproNovo, a company dedicated to developing innovative treatments for reproductive medicine and women’s health, announced the closing of a $65 million Series A financing round. The funding round was led by Jeito Capital, co-led by AXA IM A... |
| 22.05.2025 | ReproNovo's $65 Million Leap: A New Dawn for Reproductive Health | In a world where fertility rates are slipping like sand through fingers, ReproNovo emerges as a beacon of hope. This Swiss HealthTech startup, founded in 2021, has just secured $65 million in Series A financing. The funding round, led by Je... |
| 22.05.2025 | Jeito Capital leads $65 million round in ReproNovo | Jeito Capital led a $65 million Series A investment in ReproNovo ReproNovo Founded: 2021 Headquarters: Lausanne, Vaud, Switzerland See full company profile "> , a biopharma company developing treatments for reproductive medicine and... |
| 21.05.2025 | Swiss HealthTech company ReproNovo raises €57 million to tackle declining fertility rates | Lausanne-based HealthTech startup ReproNovo, a company innovating treatments for reproductive medicine and women’s health, has secured a €57 million Series A financing round. The round was led by Jeito Capital, AXA IM and M Ventures, alongs... |
| 21.05.2025 | ReproNovo raises USD65 million to advance Phase II clinical trials | ReproNovo, founded in 2021, is developing novel approaches to address critical gaps in reproductive medicine and women’s health, including male and female infertility as well as uterine health. The company, led by a team with expertise in ... |
| 21.05.2025 | ReproNovo Raises $65M in Series A Financing | ReproNovo, a Lausanne, Switzerland-based company dedicated to developing treatments for reproductive medicine and women’s health, raised $65M in Series A funding. The round was led by Jeito Capital, co-led by AXA IM Alts and founding invest... |
| - | ReproNovo | “New Scientific Approaches in Reproductive Medicine. At ReproNovo, we are passionate about bringing the dream of parenthood to life.” |